CENTOGENE, N.V. (CNTG): Aggregate Business Value

Official company branding of Centogene NV (CNTG)

Centogene N.V. is developing digital biodata processing systems for the rapid identification of rare pathologies, while the current market quotes visualized below reflect an Enterprise Value of . Business growth is driven by a staff of leading bioinformaticians attracted by the uniqueness of the scientific archives. However, the high cost of technology maintenance and pressure from industry behemoths pose a threat of reducing the company's market influence.

CNTG (CENTOGENE N.V.) Total Company Value history from 07/04/2022 to 10/27/2026
Original product of centogene.com

The monolithic defensive moat of Centogene N.V., based on a unique bank of rare mutations, makes the enterprise value a key indicator for assessing this tech asset. The current is calculated as the sum of market capitalization and net debt, allowing investors to determine the actual buyout price of the business by eliminating emotional price volatility and assessing the risk of overpayment.